Background A 56-year-old white woman was referred to our institution with a 16-month history of severe, gouty, recurrent, acute polyarthritis involving the finger joints. She also had numerous small ...

Gout flare in the hand of an elderly person Researchers evaluated the efficacy and safety of anakinra for the treatment of acute gout flares. Undergoing 5 days of therapy with the IL-1 receptor ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Ilaris for the treatment of gout flares in adults, marking it as the first biologic therapy ...

Credit: Getty Images. Ilaris is an interleukin-1β blocker. The Food and Drug Administration (FDA) has approved Ilaris ® (canakinumab) for the symptomatic treatment of adult patients with gout flares ...

Researchers have identified a new therapeutic target for the treatment of gout, a common type of arthritis that causes episodes of painful and stiff joints. Their study suggests that blocking a ...

If you often find yourself sidelined by a sudden, throbbing pain in your joints, especially in your big toe, you may be suffering from a gout attack. Flare ups of this common type of arthritis can ...

Gout is the most common type of inflammatory arthritis in the world and is caused by the buildup of uric acid crystals in your joints. These crystals form when there’s too much uric acid in your blood ...

Please provide your email address to receive an email when new articles are posted on . When an individual has an excess of uric acid in the blood, it can crystallize in the joints and cause gout, the ...

An Arrowhead Pharmaceuticals “gene-silencing” drug that the biotech has been quietly researching as a gout treatment will continue its development under a partnership with Horizon Therapeutics.

Patients with gout and type 2 diabetes treated with SGLT2 inhibitors not only had reduced numbers of gout flares, but also lived longer compared with other such patients receiving other medications, ...

Get the latest news on coronavirus and more delivered daily to your inbox. Sign up here. A team of researchers in New York is pairing with another group in Montreal to explore whether a common ...